Exome Asset Management LLC Savara Inc Transaction History
Exome Asset Management LLC
- $112 Billion
- Q1 2025
A detailed history of Exome Asset Management LLC transactions in Savara Inc stock. As of the latest transaction made, Exome Asset Management LLC holds 836,397 shares of SVRA stock, worth $1.91 Million. This represents 2.06% of its overall portfolio holdings.
Number of Shares
836,397
Previous 699,698
19.54%
Holding current value
$1.91 Million
Previous $2.15 Billion
7.86%
% of portfolio
2.06%
Previous 1.61%
Shares
2 transactions
Others Institutions Holding SVRA
# of Institutions
142Shares Held
162MCall Options Held
54.8KPut Options Held
4.1K-
Nea Management Company, LLC Timonium, MD24.5MShares$55.8 Million6.43% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA17.6MShares$40.1 Million16.36% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$28.2 Million8.25% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA11.5MShares$26.1 Million2.0% of portfolio
-
Vestal Point Capital, LP New York, NY11MShares$25.1 Million2.18% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $260M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.